Prostatic Urethral Lift: A Unique Minimally Invasive Surgical Treatment of Male Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia

Abstract

The prostatic urethral lift (PUL) is a unique, nonthermal approach to treating lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH). It can be conducted under local anesthesia in an outpatient setting. In published clinical studies, most voiding tested patients do not require a catheter. After PUL, patients experience rapid recovery with minimal adverse effects. Average symptom response is significant by 2 weeks, improves through 3 months, and remains stable through 4 years. Erectile and ejaculatory functions are preserved. This treatment represents a desirable solution for many patients who currently have male LUTS secondary to BPH.

Keywords: Benign prostatic hyperplasia; Lower urinary tract symptoms; Minimally invasive therapy; Prostatic urethral lift; Sexual function; Surgical therapy.